Case report: Artesunate for severe acute Plasmodium falciparum infection in a patient with myasthenia gravis

Abstract

We report a case of severe malaria in a patient with underlying myasthenia gravis who was successfully treated with artesunate. The outcome was favorable. Artesunate seems to be a good option for patients with underlying myasthenia gravis disease because they benefit from a better toxicity profile than quinine. Copyright © 2012 by The American Society of Tropical Medicine and Hygiene.